MicroPort Firebird 2 Successfully Registered in Ecuador
Shanghai, July 9, 2012--MicroPort announced the registration for MicroPort Firebird2 Rapamycin-Eluting CoCr Coronary Stent System has been approved by Ecuador's FDA. It is the third product has successfully launched in the country after Firebird and Mustang. Currently, Firebird2 has successfully entered into eight countries includes Philippines, Thailand, Indonesia, Argentina, Brazil, Venezuela, Peru, and Ecuador.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.